$2.74 Billion Next-Generation Sequencing (NGS) Services Market 2017 - Global Forecasts to 2022
DUBLIN, September 8, 2017 /PRNewswire/ --
The "Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022" report has been added to Research and Markets' offering.
The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 Million by 2022 from USD 1,059.2 Million in 2017, growing at a CAGR of 21.0% during the forecast period
Factors such as technological advancements in the field of robot-assisted surgeries, increasing number of minimally-invasive surgeries, and growing patient preference for affordable & effective surgical treatments are driving the growth of this market.
The report analyzes the global NGS services market by type, technology, application, end user, and region. Based on type, the targeted resequencing & custom gene panels segment accounted for the largest share of the market; owing it to the advantages of targeted resequencing it offers over conventional methods and development of technologically advanced NGS products and services for targeted resequencing.
Sequencing by synthesis technology accounted for the largest market share owing to the introduction of technologically advanced SBS platforms in the market which allows more efficient sequencing and reduces the cost of sequencing. Based on applications, the NGS services market is segmented into diagnostics, drug discovery, biomarker discovery, agriculture & animal research, and other applications. The diagnostics segment is estimated to account for the largest share of the global NGS services market in 2017 owing to its growing number of target diseases across the globe and technological advancements to support a wider range of NGS-based applications.
This report covers the NGS services market value data across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global NGS services market in 2016, followed by Europe.
The large share in the North American region is mainly attributed to the presence of leading NGS service providers in the region, declining cost of sequencing, rising awareness of NGS services, increasing number of NGS-based research & clinical applications in the region, high incidence of target diseases such as cancer, and the favorable reimbursement scenario in the region.
The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the rapid growth in the genomic research and NGS based diagnostics in emerging Asia-Pacific countries such as China and India, which will support the adoption of NGS services.
Market Dynamics
Drivers
- Declining Price of Sequencing
- High Cost of Sequencing Infrastructure
- Need for Skilled Professionals for Efficient Ngs Sample Preparation And Analysis
- Sequencing Services, the Preferred Option for Ngs Applications With Low Throughput Requirements
- Technological Advancements in the Field of Sequencing
Restraints
- Installation of In-House Sequencing Facilities in Hospitals And Universities
Opportunities
- Analysis of Complex Sequencing Data
- Increasing Applications in Cancer And Agrigenomics Research
Challenges
- Accuracy & Standardization Concerns in Diagnostic Testing
- Ethical Issues Related to Nipt
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Next-Generation Sequencing Services Market, By Technology
7 Global Ngs Services Market, By Service Type
8 Next-Generation Sequencing Services Market, By Application
9 Next-Generation Sequencing Services Market, By End User
10 Global Next-Generation Sequencing Services Market, By Region
11 Competitive Landscape
12 Company Profiles
- BGI
- Centogene Ag
- Dna Link Inc
- Eurofins Scientific Se
- Gatc Biotech Ag
- Genewiz Inc.
- Genomics Biosci & Tech. Co. Ltd.
- Genotypic Technology Pvt Ltd.
- Illumina Inc.
- Integragen Sa
- Lgc Limited (A Part of Kkr & Co. L.P.)
- Macrogen Inc.
- Novogene Corporation
- Otogenetics Corporation
- Oxford Gene Technology
- Perkinelmer Inc..
- Personalis Inc.
- Qiagen N.V.
- Scigenom Labs Pvt. Ltd
- Source Bioscience
- Sysmex Corporation
- Takara Bio Inc.
- Theragen Etex Co. Ltd.
- Wuxi Apptec
- Zymo Research Corp
For more information about this report visit https://www.researchandmarkets.com/research/5p65wj/nextgeneration
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article